Alliance A091404: a phase II study of enzalutamide (nsc# 766085) for patients with androgen receptor positive salivary cancers
- Citation:
- J Clin Oncol vol 37 (15_suppl) 6020-6020
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3705
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Astellas
- Grants:
- U10CA180821, U10CA180882, U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Alan Loh Ho Nathan R. Foster Alex J. Zoroufy Francis Worden Katharine Price Douglas Adkins Daniel W. Bowles Hyunseok Kang Barbara Burtness Eric Sherman Roscoe Morton Nora Katabi Pamela Munster Gary K. Schwartz
- Networks:
- CA136, COLUMBIA, IWORC, LAPS-CO070, LAPS-CT018, LAPS-MN026, LAPS-MO011, LAPS-NY016, MI014
- Study
- Alliance-A091404
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: